The medical perfusion technology is mostly used in bypass cardiopulmonary systems to treat the patients with cardiac and respiratory diseases and helps to maintain the continuity of blood and oxygen circulation in the body during the surgery of heart and lungs. Perfusion is measured as the rate at which blood is delivered to tissues or volumes of blood per unit time per unit tissue mass. Perfusion system such as heart and lungs machines delivers oxygen and removes carbon dioxide from patient’s body when heart and lungs are not performing process of oxygenation.
The global medical perfusion technology market has experienced great growth since so long. Factors such as advancement in medical perfusion technology, increase in prevalence of cardiovascular and respiratory disease, increase in geriatric population, growing investments in research and development for medical perfusion technology and cell based research, rising numbers of organ transplantations are boosting the growth of the market. However, excessive cost of organ transfer may hamper the growth of the market.
The exclusive COVID-19 impact analysis report by axiom MRC provides a 3600 analysis of micro and macro-economic factors on the medical perfusion technology market. In addition, complete analysis of changes on medical perfusion technology expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Covid 19 has negative impact on global medical perfusion technology market. To control the spread of Covid 19 and to optimize hospital resources so many medical procedures are getting postponed which causes limiting use of medical devices such as medical perfusion system devices. Therefore, these postponed medical procedures hampering the growth of the market.
The global medical perfusion technology market has studied the segments by technique, organ type, component, and geography.
Medical perfusion technology market is segmented into two major techniques which are hypothermic machine perfusion, normothermic machine perfusion. The technique segment is dominated by hypothermic machine perfusion. Also normothermic machine perfusion is expected to dominate this segment with high CAGR during forecasting period. NMP along with extracorporeal oxygenation membrane prevents the risk of reperfusion this helps in boosting growth of the segment.
Study identified various organ types like liver, kidneys, heart and lungs. The organ type segment is dominated by kidney segment owing to the increasing cases of chronic kidney diseases and medical perfusion devices are mostly used in preservation of kidneys. Heart segment is estimated to register highest CAGR in the market during forecast period as heart failure rates are increasing due to several cardiovascular diseases.
By component, medical perfusion market is segmented into perfusion pumps, oxygenators, heart-lung machines, and monitoring system. The component segment is dominated by oxygenators in 2020. As oxygenators have increasing demand due to rise in cases of Covid 19. Also these devices have most significant aspects of critical care in surgical procedures and in management of COVID-19 patients as well, which is fuelling the segment growth.
Geographically the study comprised of the region like North America, Europe, Asia Pacific and rest of the world. By the geography the North America has dominated the market owing to the increasing cases of cardiovascular diseases. Likewise rising geriatric population and presence of the many large hospitals in the region has boosted the growth of North America medical perfusion technology market. And following to that Asia Pacific is showing the rapid market growth in the medical perfusion technology market as region includes developing nations like India, China and South Korea.
Major Key players of medical perfusion technology market are Getinge AB, Medtronic, LivaNova PLC, XVIVO Perfusion, Terumo Cardiovascular Systems Corporation, OrganOx Limited, Waters Medical Systems, TransMedics, Organ Recovery Systems, XENIOS AG, Paragonix Technologies, Shanghai Genext Medical Technology, Transplant Biomedicals SL and Dr. Franz Köhler Chemie GMBH among the others.
The study analysed several segments and their dominating or leading sub segments in the global medical perfusion market. Segments such as technique, organ type and geography are covered in the study. Dominating technique segment is hypothermic perfusion technology; organ type segment is kidney; and component segment is oxygenator. Geographically North America region has dominated the global medical perfusion technology market. The study also consists of impact of Covid 19 pandemic on the global medical perfusion technology market. It has hampered the growth of the market. As many surgical processes are postponed to stop the spread of Covid 19 Which shows negative impact on the market. Study also covers the major key players of medical perfusion technology.
April 2021: Getinge’s launched heart-lung machine HL 40, designed to increase the safety and ensure maximum uptime in cardiac surgery. This heart lung machine is designed to control the circulation of oxygenated blood during complex cardiac surgical interventions.
September 2020: Xvivo announced the agreement to acquire all shares in organ assist. Organ assist primarily focuses on developing machines for liver and kidney perfusion. By this acquisition Xvivo becomes first organ preservation and Evaluation Company in the world.
May 2019: Terumo cardiovascular group and Talis clinical announced commercial release of AGC –perfusion and AGC- remote view system in North America. It enables Terumo to distribute Tali’s clinical ACG- perfusion and ACG-Remote View Systems in cardiac operating rooms and intensive care units.
April 2019: FDA granted approval to Xvivo perfusion for its products Xp’s and Steen solution. This approval means Steen solution and Xp’s are only medical devices products which are consent in the US for Ex-vivo lung perfusion of unacceptable donated lungs at body temperature.
Why to buy this report